Cédric Atmanène

Discovery of Specific Inhibitors of Human USP7/HAUSP Deubiquitinating Enzyme

Céline Reverdy, Susan Conrath, Roman Lopez et al. · Chemistry & Biology · 2012 · 263 citations

Specific Inhibitors, Drug Target, Biochemistry +6

Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism

D.J. Marcotte, Weike Zeng, Jean‐Christophe Hus et al. · Bioorganic & Medicinal Chemistry · 2013 · 233 citations · Full text

Proteinlipid Interaction, Keap1 Kelch, Signal Transduction +12

Native Ms: An ‘Esi’ Way to Support Structure- and Fragment-Based Drug Discovery

Valérie Vivat Hannah, Cédric Atmanène, Denis Zeyer et al. · Future Medicinal Chemistry · 2009 · 86 citations

Extending Mass Spectrometry Contribution to Therapeutic Monoclonal Antibody Lead Optimization: Characterization of Immune Complexes Using Noncovalent ESI-MS

Cédric Atmanène, Elsa Wagner‐Rousset, Martine Malissard et al. · Analytical Chemistry · 2009 · 78 citations

Immunology, Biological Mass Spectrometry, Immunotherapeutics +22

One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists

J. Schiebel, Nedyalka Radeva, Helene Köster et al. · ChemMedChem · 2015 · 69 citations

Drug Target, Hit Identification, Biomolecular Structure Prediction +24